Previous studies showed the capability of 3-hydroxytyrosol and chlorogenic acid to reduce BCL-2 and caspase-3 gene and protein expression, respectively [28,29], while gentisic acid could interact with fibroblast growth factor 1 (FGF1), whose levels are increased in prostate cancer [30]. The gene discussed is FGF1; the disease is prostate cancer.